FDA advisors endorse Alzheimer’s drug Leqembi paving manner for full approval
The Alzheimer’s drug Leqembi is seen on this undated handout picture obtained by Reuters on January 20, 2023. Eisai | through Reuters A panel of impartial advisors to the Meals and Drug Administration on Friday unanimously endorsed the Alzheimer’s drug Leqembi made by Eisai and Biogenpaving the best way for full approval of the remedy … [Read more…]